Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial.
Neurocrine Biosciences Inc on Monday launched its add-on treatment for patients with Parkinson's disease nearly five months after Food and Drug Administration's approval, as the COVID-19 pandemic delayed its roll out in the United States.
Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, and forecast improving demand for its medical devices in the back half of the year as patients catch up on procedures deferred during coronavirus-induced lockdowns.
Aug 7 The U.S. Food and Drug Administration will
conduct an expedited review of an experimental Alzheimer's drug
from Biogen Inc and Japan's Eisai Co Ltd, the
companies said on Friday, the first application in 17 years to
be reviewed by the agency for a treatment of the mind-robbing
Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.
Quest Diagnostics Inc said on Thursday it expects to cut week-long turnaround times for COVID-19 tests by more than half to get to "acceptable" levels by September, responding to concerns that slow testing is hampering the U.S. response.
The U.S. Food and Drug Administration on Tuesday released guidance for approving a coronavirus vaccine, saying the vaccine has to prevent or decrease disease severity in at least 50% of people who are inoculated.
Evofem Biosciences Inc's birth control gel received the U.S. Food and Drug Administration's approval on Friday, making it the first non-hormonal contraceptive for women in over three decades, sending its shares up 3.6%.